PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Frontiers in Medical Technology0 citationsOpen Access

From basic biology to engineered therapies: the keratinocyte stem cell playbook

AUAdnan UddinMRMohamad RahmaniASAbdulrahim A. Sajini

Key Points

  • Keratinocyte stem cells drive epidermal renewal and wound repair through complex intrinsic and extrinsic mechanisms.
  • Key regulatory features include fate locks that govern differentiation, cell cycle, and mechanotransduction pathways.
  • Synthetic methods for isolation and expansion of primary human keratinocytes use advanced substrates and media formulations.
  • Emerging applications of keratinocyte-derived products include immunomodulation and ocular and mucosal regeneration.

Abstract

Keratinocyte stem cells (KSCs) are the principal drivers of epidermal renewal, barrier maintenance, and wound repair. Their ability to alternate between self-renewal and differentiation is orchestrated by tightly integrated extrinsic and intrinsic programs that ensure tissue stability while enabling rapid regeneration after injury. This review synthesizes current understanding of KSC homeostasis through a unified framework of three interdependent "fate locks"-the identity switch (ΔNp63 ↔ Notch/IRF6-KLF4/GRHL3/OVOL), the cell-cycle lock (E2F/MYC ↔ p21/p27-RB), and the mechanotransduction lock (YAP/TAZ ↔ Hippo/LATS). We summarize how niche-derived cues-integrins/ECM, EGFR, Wnt, Notch, Ca2 +/CaSR, and TGF-β-interface with intrinsic timers such as asymmetric division, DNMT1-UHRF1-mediated epigenetic memory, the DNA-damage response, proteostasis/autophagy, and redox signaling to steer keratinocyte fate. Building on this biological foundation, we categorize current methods for isolation and xeno-free expansion of primary human keratinocytes, emphasizing advances in defined media, feeder-free substrates, and biomimetic culture surfaces. We further review 3D and organotypic models, hydrogel-based delivery systems, and the growing portfolio of keratinocyte-derived clinical products used in wound healing. Finally, we highlight emerging applications extending beyond cutaneous repair-including immunomodulation, pigment restoration, ocular and mucosal regeneration, and acellular exosome-based therapeutics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Uddin et al. (2026) studied this question.

synapsesocial.com/papers/69a76728badf0bb9e87dfcc7https://doi.org/10.3389/fmedt.2026.1763067
Ask AI
Helpful
Bookmark
Share
View Full Paper